4-氟-2,5-二甲基苯硼酸 | 1072946-10-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氟-2,5-二甲基苯硼酸
• 英文名称: 4-fluoro-2,5-dimethylphenylboronic acid
• 英文别名: (4-fluoro-2,5-dimethylphenyl)boronic acid
• CAS: 1072946-10-1
• 化学式: C₈H₁₀BFO₂
• mdl: MFCD10699621
• 分子量: 167.976
• InChiKey: VZEWNOKICGAJPJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.71
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2931900090

反应信息

• 作为反应物：
  描述：

  2-氨基-4,6-二氯嘧啶 、 4-氟-2,5-二甲基苯硼酸 在 四(三苯基膦)钯 、 potassium carbonate 作用下， 以 1,4-二氧六环 、 水 为溶剂， 反应 23.0h， 生成 4-chloro-6-(4-fluoro-2,5-dimethylphenyl)pyrimidin-2-amine
  参考文献：
  名称：

  [EN] MTH1 INHIBITORS FOR TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS
  [FR] INHIBITEURS DE MTH1 DESTINÉS AU TRAITEMENT DES ÉTATS INFLAMMATOIRES ET AUTO-IMMUNS

  摘要：

  化合物的化学式（I），或其药学上可接受的盐，用于治疗自身免疫性疾病和炎症性疾病。

  公开号：

  WO2015187089A1

文献信息

• COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM
  申请人：Whitten Jeffrey P.

  公开号：US20110263612A1

  公开（公告）日：2011-10-27

  Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

  本文描述了含有这些化合物的化合物和药物组合物，这些化合物调节储存操作钙（SOC）通道的活性。本文还描述了使用这种SOC通道调节剂的方法，单独或与其他化合物结合，用于治疗需要抑制SOC通道活性的疾病或症状。
• [EN] MTH1 INHIBITORS FOR TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS<br/>[FR] INHIBITEURS DE MTH1 DESTINÉS AU TRAITEMENT DES ÉTATS INFLAMMATOIRES ET AUTO-IMMUNS
  申请人：THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING

  公开号：WO2015187089A1

  公开（公告）日：2015-12-10

  A compound of formula (I), or a pharmaceutically acceptable salt thereof, for use in the treatment of autoimmune diseases and inflammatory conditions.

  化合物的化学式（I），或其药学上可接受的盐，用于治疗自身免疫性疾病和炎症性疾病。
• [EN] WDR5 INHIBITORS AND MODULATORS<br/>[FR] MODULATEURS ET INHIBITEURS DE WDR5
  申请人：UNIV VANDERBILT

  公开号：WO2020247679A1

  公开（公告）日：2020-12-10

  Quinazolin-4(3H)-one, 2,3 -dihydroquinazolin-4(1H)-one, 3,4-dihydrobenzo[f][1,4]oxazepin- 5(2H)-one, and 3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione compounds and derivatives inhibit WDR5 and associated protein-protein interactions, and the compounds and their pharmaceutical compositions are useful for treating disorders and conditions in a subject, such as cancer cell proliferation.

  喹唑啉-4(3H)-酮，2,3-二氢喹唑啉-4(1H)-酮，3,4-二氢苯并[f][1,4]噁唑啉-5(2H)-酮，以及3,4-二氢-1H-苯并[e][1,4]二氮杂环己二酮化合物及其衍生物抑制WDR5及相关蛋白质相互作用，这些化合物及其药物组合物可用于治疗受试者的疾病和症状，如癌细胞增殖。
• Pyrimidine-2,4-Diamine Derivatives for Treatment of Cancer
  申请人：THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING

  公开号：US20160002175A1

  公开（公告）日：2016-01-07

  A compound of formula (I), or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.

  公式（I）的化合物，或其药学上可接受的盐。该化合物可用于治疗癌症或其他可能从MTH1抑制中受益的疾病。
• Synthesis and biological evaluation of novel 2-oxo-1,2-dihydroquinoline-4-carboxamide derivatives for the treatment of esophageal squamous cell carcinoma
  作者：Mai I. Shahin、Joyeeta Roy、Maha Hanafi、Dongyao Wang、Urarika Luesakul、Yifeng Chai、Nongnuj Muangsin、Deena S. Lasheen、Dalal A. Abou El Ella、Khaled A. Abouzid、Nouri Neamati

  DOI：10.1016/j.ejmech.2018.05.042

  日期：2018.7

  No new and effective treatments have been approved for the treatment of esophageal squamous cell carcinoma (ESCC) in the past decade. Cisplatin and 5-fluoruracil are the most commonly used drugs for this disease. In order to develop a new class of drugs effective in our ESCC phenotypic screens, we began a systematic approach to generate novel compounds based on the 2-oxo-1,2-dihydroquinoline-4carboxamide fragment. Herein, we report on the synthesis and initial assessment of 55 new analogues in two ESCC cell lines. Some of the active analogues with 1050 values around 10 mu M were tested in three additional cell lines. Our structure-activity relationships revealed remarkable alterations in the anti proliferative activities upon modest chemical modifications and autophagy modulation is a suggested mechanism of action. (C) 2018 Elsevier Masson SAS. All rights reserved.